About - Prof. Dr Ahmet Elmaagacli
About Prof. Dr. med. Ahmet Elmaagacli: A Leader in Hematology and Stem Cell Transplantation
Prof. Dr. med. Ahmet Elmaagacli is a world-renowned hematologist in Hamburg, Germany, currently serving as the Chief Physician (Chefarzt) of the Department of Hematology, Oncology, and Stem Cell Transplantation at the prestigious Asklepios Klinik Sankt Georg. With a career spanning several decades, Prof. Elmaagacli has established himself as a leading authority in the treatment of complex blood cancers and is a pioneer in the field of allogeneic stem cell transplantation.
Under his leadership, the department at Asklepios Klinik Sankt Georg has become one of the largest and most respected centers for stem cell transplantation in Europe. Prof. Elmaagacli is widely recognized for his clinical expertise in managing high-risk cases of leukemia, lymphoma, and multiple myeloma. His approach combines cutting-edge medical technology with a deep commitment to patient-centered care, ensuring that every individual receives a personalized treatment plan tailored to their specific diagnosis and molecular profile.
As a specialist in internal medicine, hematology, and oncology, Prof. Elmaagacli has been instrumental in advancing unrelated donor transplantation and haploidentical transplantation techniques. His work has significantly improved survival rates and quality of life for patients who previously had limited treatment options. Patients from across Germany and the international community seek his expertise for bone marrow transplants and innovative immunotherapy treatments.
Key Stats & Information
- Years of Experience: 25+ Years
- Primary Specialization: Hematology, Oncology, and Stem Cell Transplantation
- Current Position: Chief Physician (Chefarzt) at Asklepios Klinik Sankt Georg
- Key Expertise: Allogeneic and Autologous Stem Cell Transplantation
- Languages Spoken: German, English
- Hospital Privileges: Asklepios Klinik Sankt Georg, Hamburg
- Accreditation: JACIE Certified Stem Cell Transplant Center
- Accepting New Patients: Yes
Medical Expertise & Specializations
Prof. Dr. Ahmet Elmaagacli’s medical expertise is centered on the comprehensive diagnosis and treatment of malignant diseases of the blood and lymphatic system. His department is a national reference center for stem cell transplantation in Germany, performing a high volume of procedures annually with exceptional clinical outcomes. Prof. Elmaagacli’s specialization extends to the most advanced forms of cellular therapy, including the management of complex graft-versus-host disease (GvHD) and the integration of novel pharmacological agents into transplant protocols.
His clinical philosophy is rooted in the "bench-to-bedside" approach, ensuring that the latest scientific research is rapidly translated into clinical practice. This is particularly evident in the treatment of acute leukemias, where Prof. Elmaagacli utilizes sophisticated molecular diagnostics to guide targeted therapies and determine the optimal timing for transplantation. The department's status as a JACIE-accredited facility underscores its adherence to the highest international standards for cell collection, processing, and clinical application.
Conditions Treated
Prof. Dr. Elmaagacli specializes in the treatment of a wide range of hematological and oncological conditions. His expertise is particularly sought after for:
- Acute Myeloid Leukemia (AML): Providing comprehensive care from induction chemotherapy to allogeneic stem cell transplantation for high-risk AML patients.
- Acute Lymphoblastic Leukemia (ALL): Utilizing advanced protocols for both adult and pediatric-type ALL cases.
- Chronic Myeloid Leukemia (CML) and CLL: Managing long-term therapy with TKI inhibitors and addressing treatment-resistant cases.
- Malignant Lymphomas: Including Hodgkin’s Lymphoma and a broad spectrum of Non-Hodgkin Lymphomas (NHL) such as Diffuse Large B-Cell Lymphoma (DLBCL) and Follicular Lymphoma.
- Multiple Myeloma: Implementing multi-modal treatment strategies involving autologous stem cell transplantation and the latest proteasome inhibitors and immunomodulators.
- Myelodysplastic Syndromes (MDS): Specialized care for patients with bone marrow failure and those at risk of progression to acute leukemia.
- Myeloproliferative Neoplasms (MPN): Including Polycythemia Vera, Essential Thrombocythemia, and Myelofibrosis.
- Coagulation Disorders: Expert diagnosis and management of complex bleeding and clotting disorders.
Procedures Performed
As a leading hematologist and transplant specialist in Hamburg, Prof. Elmaagacli performs and oversees several critical procedures:
- Allogeneic Stem Cell Transplantation: Utilizing stem cells from related or unrelated donors to treat aggressive blood cancers.
- Autologous Stem Cell Transplantation: Using the patient's own harvested stem cells to support high-dose chemotherapy treatments.
- Haploidentical Transplantation: Advanced transplant techniques using "half-matched" family donors, expanding the donor pool for patients in urgent need.
- High-Dose Chemotherapy: Intensive drug regimens designed to eliminate cancer cells, often followed by stem cell rescue.
- Bone Marrow Aspiration and Biopsy: Precision diagnostics to monitor disease progression and treatment response.
- Immunotherapy and Targeted Therapy: Administration of monoclonal antibodies and specific inhibitors targeted at cancer cell mutations.
- CAR-T Cell Therapy Support: Coordination and management of patients undergoing advanced cellular immunotherapies.
Education and Training
Prof. Dr. med. Ahmet Elmaagacli possesses an extensive academic and clinical background that serves as the foundation for his leadership in hematology. His medical education and subsequent specialization were completed at some of the most prestigious institutions in Germany, where he focused on the complexities of blood-forming systems and oncology.
- Medical Degree: Completed at a leading German University Medical Faculty, followed by specialized training in Internal Medicine.
- Specialization in Hematology and Oncology: Board certification in Internal Medicine with a sub-specialization in Hematology and Medical Oncology.
- Academic Appointment: Professorship at the University Hospital Essen (Universitätsklinikum Essen), where he held a leading position in the Bone Marrow Transplant Center before moving to Hamburg.
- Chief Physician Appointment: Appointed as the Chief Physician of Hematology and Oncology at Asklepios Klinik Sankt Georg in 2011.
- Continuing Medical Education: Regularly serves as a primary investigator in international clinical trials and is an active member of the German Society for Hematology and Medical Oncology (DGHO) and the European Society for Blood and Marrow Transplantation (EBMT).
Frequently Asked Questions (FAQ)
What makes Prof. Dr. Ahmet Elmaagacli a specialist in stem cell transplantation?
Prof. Elmaagacli is considered a specialist due to his decades of experience and his role as Chief Physician at one of Europe's largest transplant centers. He has performed thousands of transplants and is a pioneer in unrelated and haploidentical transplantation. His department is JACIE-certified, which is the gold standard for quality in this medical field.
What types of leukemia does Prof. Elmaagacli treat in Hamburg?
He treats all forms of adult leukemia, including Acute Myeloid Leukemia (AML), Acute Lymphoblastic Leukemia (ALL), Chronic Myeloid Leukemia (CML), and Chronic Lymphocytic Leukemia (CLL). He specializes in using molecular profiling to determine the best course of action, whether it be targeted therapy or a stem cell transplant.
How do I get a second opinion from Prof. Elmaagacli for a blood cancer diagnosis?
Patients can request a second opinion by contacting the Department of Hematology at Asklepios Klinik Sankt Georg. Prof. Elmaagacli and his team review existing diagnostic reports and pathology to provide a comprehensive evaluation of the recommended treatment plan, often offering alternative or more advanced therapy options.
What is the success rate of stem cell transplants at Asklepios Sankt Georg?
The success rates at Prof. Elmaagacli’s department are among the highest in Germany, consistently meeting or exceeding European benchmarks. The center’s extensive experience with high-risk patients and its JACIE accreditation ensure the highest safety standards and clinical outcomes for both autologous and allogeneic procedures.
Does Prof. Elmaagacli treat international patients?
Yes, Prof. Elmaagacli and the Asklepios Klinik Sankt Georg frequently treat international patients. The hospital has dedicated infrastructure to assist international patients with the necessary documentation, translation services, and logistical support required for treatment in Hamburg, Germany.
What is allogeneic stem cell transplantation?
Allogeneic transplantation involves transferring healthy stem cells from a donor (either a family member or an unrelated volunteer) to the patient. Prof. Elmaagacli uses this procedure to treat aggressive blood cancers by replacing the diseased bone marrow with a healthy immune system capable of fighting the cancer.
How long is the recovery period after a bone marrow transplant?
The initial recovery phase usually requires 3 to 4 weeks of inpatient care in a specialized isolation ward to protect the patient while their new immune system develops. Full recovery and the return to daily activities can take several months, during which Prof. Elmaagacli’s team provides intensive outpatient follow-up care.
What are the advantages of being treated at a JACIE-certified center?
JACIE certification ensures that the facility follows a rigorous set of international standards for every step of the transplant process. For patients of Prof. Elmaagacli, this means a guarantee of quality in stem cell collection, laboratory processing, and clinical care, which directly correlates with improved patient safety.
Does the department offer CAR-T cell therapy?
Prof. Elmaagacli’s department is at the forefront of cellular immunotherapy. They provide comprehensive management and support for patients receiving advanced therapies like CAR-T, focusing on managing potential side effects and integrating these treatments into broader oncological strategies.
What technologies are used in the diagnosis of hematological diseases?
The department utilizes state-of-the-art diagnostics, including flow cytometry, cytogenetics, and Next-Generation Sequencing (NGS). These technologies allow Prof. Elmaagacli to identify specific genetic mutations in cancer cells, which is essential for choosing the most effective targeted therapies.
Ready to Consult with Prof. Dr. Ahmet Elmaagacli in Hamburg?
Managing a serious hematological diagnosis requires expertise, precision, and access to the world’s most advanced medical treatments. PlacidWay partners with top-tier medical professionals like Prof. Dr. med. Ahmet Elmaagacli to provide you with seamless access to world-class hematology and oncology care in Germany.
Contact PlacidWay today to schedule your consultation with Prof. Elmaagacli, receive assistance with your medical travel arrangements, and take the first step toward receiving life-saving treatment at one of Europe’s premier medical institutions. Our team is here to support you throughout your journey to recovery.
Important Disclaimer
PlacidWay.com provides medical travel information, not healthcare services. We don't endorse any providers, and we're not responsible for the care you receive.
Pricing: Prices on our site are estimates only, provided by the centers. Always confirm actual prices directly with the provider before booking to ensure full transparency and avoid hidden fees.
Your Health: Consult your local licensed healthcare provider before pursuing any treatment found on our site. Your health decisions are your responsibility.
Share this listing